DxTerity Diagnostics Begins Enrollment in the ELEVATE Clinical Study for Lupus

ELEVATE aims to identify biomarkers for the advancement of SLE precision medicine LOS ANGELES, May 27, 2022 /PRNewswire/ — DxTerity Diagnostics today announced the opening of enrollment in ELEVATE (Empower Lupus Erythematous Patients Via Allowing RemoTe Evaluation), a new observational…